Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine and butorphanol for prevention of awareness during emergence from general anesthesia
ChiCTR1800016750Phase 4Recruiting
- Sponsor
- Cancer Hospital of Guangxi Medical University
- Start
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of dexmedetomidine and butorphanol in Anesthesia awareness (AAGA) (4 arms), sponsored by Cancer Hospital of Guangxi Medical University. Primary endpoint: Awareness rate of extubation. Started Aug 2018; status: recruiting.
02
Drugs
dexmedetomidinebutorphanol
03
Conditions
Anesthesia awareness (AAGA)
Beyond the preview
Go deeper on ChiCTR1800016750.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800016750.